Company profile for Solaxa

Solaxa

Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

Contact Supplier

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

Contact Supplier

AMI Lifesciences is Driven by Chemistry. Powered by People.

Contact Supplier

pharmacompass-2-m-2025-11-03

Contact Supplier

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

DIGITAL CONTENT

1 News #PharmaBuzz

media
1 News #PharmaBuzz

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Solaxa Inc. is a clinical-stage biopharmaceutical public benefit corporation dedicated to restoring nerve function in patients with rare neurodegenerative diseases and acute nerve injuries. Utilizing a proprietary class of aminopyridine drugs, Solaxa targets ion channel dysfunction to detect and treat conditions like spinocerebellar ataxia. The company has received FDA orphan drug designation and collaborates with the Natio...

Solaxa Inc. is a clinical-stage biopharmaceutical public benefit corporation dedicated to restoring nerve function in patients with rare neurodegenerative diseases and acute nerve injuries. Utilizing a proprietary class of aminopyridine drugs, Solaxa targets ion channel dysfunction to detect and treat conditions like spinocerebellar ataxia. The company has received FDA orphan drug designation and collaborates with the National Ataxia Foundation to advance research and patient access. Solaxa's mission is to deliver accessible, impactful therapies that improve outcomes for patients worldwide.

DCAT WeekDCAT Week

Not Confirmed

Not Confirmed

23-26 March, 2026

New York, U.S.A
Global ChemShowGlobal ChemShow

Not Confirmed

Not Confirmed

19-20 December, 2025

Bombay Exhibition Centre, Mumbai
BIO Partnering at JPMBIO Partnering at JPM

Not Confirmed

Not Confirmed

12-15 January, 2026

San Francisco Marriott Marquis, California

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown

United_States_of_America Flag

Country

Country

U.S.A

Address

Address

7272 Wisconsin Ave 9th floor Bethesda, MD 20814

Telephone

Telephone

Email

enquiries@pharmacompass.com

Client Website

Website

https://www.solaxa.com/

Linkedin

youtube

YouTube

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

Solaxa Announces Phase 3 Trial for Ataxia Type 27B

28 Mar 2025

// ACCESSWIRE

Drugs in Development

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Market Place

Home

Menu

Post Enquiry

Market Place

Search